Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Garzotto

Showing results (21-30 of 77) with videos related to

Pageof 8
Sort By:
Cancer|May 15, 2013
Agent Orange as a risk factor for high-grade prostate cancerNathan Ansbaugh, Jackilen Shannon, Motomi Mori, et al.
Urology|April 19, 2005
Prostate-specific antigen decline after gonadotropin-releasing hormone antagonist withdrawal in androgen-independent prostate cancerMatthew Wagner, Mark Garzotto, Dianne Lemmon, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|August 23, 2019
Phytol and its metabolites phytanic and pristanic acids for risk of cancer: current evidence and future directionsGerd Bobe, Zhenzhen Zhang, Ryan Kopp, et al.
Cancer|February 11, 2004
Quality of life and pain relief during treatment with calcitriol and docetaxel in symptomatic metastatic androgen-independent prostate carcinomaTomasz M Beer, Kristine M Eilers, Mark Garzotto, et al.
Urology|February 20, 2004
Targeting FSH in androgen-independent prostate cancer: abarelix for prostate cancer progressing after orchiectomyTomasz M Beer, Mark Garzotto, Kristi M Eilers, et al.
The Journal of Urology|August 12, 2005
High dose pulse calcitriol, docetaxel and estramustine for androgen independent prostate cancer: a phase I/II studyNatasha M Tiffany, Christopher W Ryan, Mark Garzotto, et al.
Nutrients|July 19, 2019
Dairy Product Consumption and Prostate Cancer Risk in the United StatesIsabella Preble, Zhenzhen Zhang, Ryan Kopp, et al.
International Journal of Radiation Oncology, Biology, Physics|August 12, 2003
A comparison of CT scan to transrectal ultrasound-measured prostate volume in untreated prostate cancerS Christopher Hoffelt, Lynn M Marshall, Mark Garzotto, et al.
Cancer|July 20, 2007
Diethylstilbestrol and docetaxel: a Phase II study of tubulin active agents in patients with metastatic, androgen-independent prostate cancerR Bruce Montgomery, Peter S Nelson, Daniel Lin, et al.
Clinical Genitourinary Cancer|June 1, 2022
Calibrated Regression Models Based on the Risk of Clinical Nodal Metastasis Should be Used as Decision Aids for Prostate Cancer Staging to Reduce Unnecessary ImagingMitchell Hayes, Yun Yu, Solange Bassale, et al.
Pageof 8

Showing results (21-30 of 77) with videos related to

Sort By:
Pageof 8
Cancer|May 15, 2013
Agent Orange as a risk factor for high-grade prostate cancerNathan Ansbaugh, Jackilen Shannon, Motomi Mori, et al.
Urology|April 19, 2005
Prostate-specific antigen decline after gonadotropin-releasing hormone antagonist withdrawal in androgen-independent prostate cancerMatthew Wagner, Mark Garzotto, Dianne Lemmon, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|August 23, 2019
Phytol and its metabolites phytanic and pristanic acids for risk of cancer: current evidence and future directionsGerd Bobe, Zhenzhen Zhang, Ryan Kopp, et al.
Cancer|February 11, 2004
Quality of life and pain relief during treatment with calcitriol and docetaxel in symptomatic metastatic androgen-independent prostate carcinomaTomasz M Beer, Kristine M Eilers, Mark Garzotto, et al.
Urology|February 20, 2004
Targeting FSH in androgen-independent prostate cancer: abarelix for prostate cancer progressing after orchiectomyTomasz M Beer, Mark Garzotto, Kristi M Eilers, et al.
The Journal of Urology|August 12, 2005
High dose pulse calcitriol, docetaxel and estramustine for androgen independent prostate cancer: a phase I/II studyNatasha M Tiffany, Christopher W Ryan, Mark Garzotto, et al.
Nutrients|July 19, 2019
Dairy Product Consumption and Prostate Cancer Risk in the United StatesIsabella Preble, Zhenzhen Zhang, Ryan Kopp, et al.
International Journal of Radiation Oncology, Biology, Physics|August 12, 2003
A comparison of CT scan to transrectal ultrasound-measured prostate volume in untreated prostate cancerS Christopher Hoffelt, Lynn M Marshall, Mark Garzotto, et al.
Cancer|July 20, 2007
Diethylstilbestrol and docetaxel: a Phase II study of tubulin active agents in patients with metastatic, androgen-independent prostate cancerR Bruce Montgomery, Peter S Nelson, Daniel Lin, et al.
Clinical Genitourinary Cancer|June 1, 2022
Calibrated Regression Models Based on the Risk of Clinical Nodal Metastasis Should be Used as Decision Aids for Prostate Cancer Staging to Reduce Unnecessary ImagingMitchell Hayes, Yun Yu, Solange Bassale, et al.
Pageof 8